Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

WHAT'S NEW

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 8 2021

Full Issue

Perspectives: Mail-Order Prescriptions Unfairly Ensnared In War On Opioids

Read recent commentaries about drug-cost issues.

The Hill: Access To Safe, Affordable Medication Is A Casualty Of The War On Opioids

Importing opioids for the purpose of drug abuse is not the same thing as importing lifesaving medication, and it is critical that regulators treat them differently — and the law strongly encourages them to do so. Since 2018, taxpayer funding for Food and Drug Administration activities has increased substantially for the purpose of stopping illegal opioids from coming into the country through international mail facilities. With that convenient window dressing, those taxpayer dollars and new federal laws are now being used to take away prescription drug orders at those same international mail facilities, which are often placed by patients who cannot afford them domestically.  (Gabriel Levitt, 8/31)

The Baltimore Sun: Reps. Brown And Mfume: Congress Must Act To Lower Prescription Drug Prices

It’s been nearly two years since our dear friend Elijah Cummings died. In that time, we have mourned his loss, lived through a pandemic, faced a reckoning on racial injustice and experienced a monumental election, in which the American people put their faith in Democrats to build our country back and enact change to better the lives of working families. In this time of building back better, we know Elijah would have pushed us to think of those who are struggling the most. With rising health care costs for COVID long-haulers, we need to focus on lowering prescription drug prices for Americans. Throughout his many years of service to Maryland and our nation, Elijah was a staunch advocate for lowering the price of prescription drugs because of the toll such costs took on families, often Black and brown families, who are less likely to have coverage or resources but more likely to need treatments for chronic diseases including asthma and diabetes. (Anthony Brown and Kweisi Mfume, 9/7)

Stat: To Lower Drug Costs, Define 'Cost' To Mean Net Cost After Rebates 

In what could be a turning point in the prescription drug debate, President Biden has made clear that the health crisis of unaffordable medications must end. In a speech he gave in the East Room of the White House in August, the president shared how he and his siblings had to chip in to cover the cost of their mother’s prescription drugs as she got older, spending thousands of dollars per month. The Bidens’ experience is shared by millions of other American seniors and families. Everyday Americans are making impossible choices between affording food and rent or their prescriptions. In many cases, people skip doses or forego treatment altogether. The effects of these choices are grim. An estimated 1 million or more Medicare patients will die prematurely between now and 2030 because they cannot afford their prescription drugs. (Sean Dickson, 9/7)

Arizona Republic: Medicare Must Negotiate Drug Prices. It's The Only Way To Lower Costs

People of all ages are skipping pills because they can’t afford their medication. That’s because Americans are paying three times what people in other countries pay for the same medicine. People are sick and tired of being price-gouged for the medicine they need. So they are calling on the president and Congress to take action toward negotiated pricing. (Alex Juarez, 8/31)

The Motley Fool: Why GoodRx Is The Antidote To High Drug Prices

When GoodRx founder Doug Hirsch realized that Americans lacked a one-stop destination for prescription discounts and prices, he decided to build an app where consumers could get the cheapest prescriptions available. With its unique customer-centric business, GoodRx holds a key competitive advantage in the industry, and its growing popularity could enable the company to become a product that every American uses.  (Jamie Louko, 9/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF